首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   102308篇
  免费   6846篇
  国内免费   2690篇
耳鼻咽喉   424篇
儿科学   2071篇
妇产科学   942篇
基础医学   6279篇
口腔科学   376篇
临床医学   13743篇
内科学   28377篇
皮肤病学   167篇
神经病学   4371篇
特种医学   9295篇
外国民族医学   9篇
外科学   10695篇
综合类   18139篇
现状与发展   6篇
预防医学   3425篇
眼科学   1839篇
药学   7181篇
  72篇
中国医学   2888篇
肿瘤学   1545篇
  2024年   162篇
  2023年   1536篇
  2022年   2252篇
  2021年   4210篇
  2020年   3978篇
  2019年   3445篇
  2018年   3462篇
  2017年   3322篇
  2016年   3451篇
  2015年   3581篇
  2014年   7112篇
  2013年   7151篇
  2012年   6083篇
  2011年   6514篇
  2010年   5479篇
  2009年   5263篇
  2008年   5220篇
  2007年   5282篇
  2006年   4845篇
  2005年   4042篇
  2004年   3286篇
  2003年   2808篇
  2002年   2341篇
  2001年   2158篇
  2000年   1681篇
  1999年   1497篇
  1998年   1427篇
  1997年   1331篇
  1996年   1084篇
  1995年   1049篇
  1994年   889篇
  1993年   749篇
  1992年   692篇
  1991年   548篇
  1990年   505篇
  1989年   427篇
  1988年   388篇
  1987年   348篇
  1986年   307篇
  1985年   400篇
  1984年   316篇
  1983年   164篇
  1982年   234篇
  1981年   179篇
  1980年   162篇
  1979年   128篇
  1978年   111篇
  1977年   78篇
  1976年   67篇
  1975年   39篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
目的:探究风池穴不同刺法对椎动脉型颈椎病的临床疗效。方法:选择2018年4月—2019年1月北京中医药大学东直门医院针灸科门诊就诊的84例椎动脉型颈椎病患者作为研究对象,分为观察组43例、对照组41例。观察组采用短刺法针刺风池穴治疗,对照组采用平补平泻法针刺风池穴治疗,1个疗程后比较两组患者的ESCV、颈椎病症状分级量化表评分以及TCD相关指标,TCD指标观察基底动脉和双侧椎动脉的平均血流速度(Vm)、收缩期血流速度峰值(Vs)、血管搏动指数(PI)和血管阻力指数(RI)的变化。结果:治疗前后两组ESCV、颈椎病症状分级量化表评分比较,差异有统计学意义(P<0.05),且椎动脉、基底动脉的Vs、Vm较治疗前明显减慢,且观察组治疗效果优于对照组(P<0.05)。结论:针刺风池穴治疗椎动脉型颈椎病临床效果显著,且短刺法优于平补平泻法。  相似文献   
92.
经皮肺动脉瓣植入术(PPVI)在我国作为一种新兴的技术,开展相对较晚,但随着我国医疗水平的不断提高以及临床对于右心室流出道梗阻的先天性心脏病患者术后出现重度肺动脉瓣反流的不断重视,PPVI在我国得到了飞速发展。近十几年来,欧美国家已在临床成熟应用PPVI,相对于传统外科手术而言其具有微创、可重复性、术后疗效好等优点。现对PPVI在肺动脉瓣反流患者中的临床应用进行叙述。  相似文献   
93.
目的 观察SWIM技术治疗后循环大血管闭塞所致急性缺血性卒中的有效性及安全性。 方法 回顾性分析2017年2月-2018年11月于大连市中心医院采用SWIM技术治疗的后循环大血管闭 塞所致急性缺血性卒中患者的临床资料,评价该技术的疗效和安全性,并分析影响患者预后的因素。 观察指标为术后即刻成功再通(mTICI≥2b)、90 d良好预后(mRS评分≤2分),以及术后24 h任何颅内 出血、90 d全因死亡。 结果 共纳入35例患者,平均年龄66.1±12.1岁,男性26例(74.3%),基线NIHSS评分22(15~34)分。 术后即刻成功再通率为94.3%(33/35),90 d良好预后率为45.7%(16/35),24 h颅内出血率为17.1% (6/35),90 d全因死亡率为37.1%(13/35)。单因素分析显示,基线NIHSS评分较低(P =0.001)、基 线后循环ASPECTS评分较高(P =0.016)、发病至到院时间较短(P =0.039)、发病至再通时间较短 (P =0.047)、血管成功再通率较高(P =0.036)以及饮酒比例较低(P =0.042)与良好预后相关。 结论 使用SWIM技术治疗后循环急性缺血性卒中相对安全、有效。  相似文献   
94.
结合国内外中西医肺康复的研究成果,探讨重型/危重型新型冠状病毒肺炎机械通气患者的肺康复策略。机械通气是治疗重型/危重型肺炎必不可少的支持手段,但可能引起呼吸肌无力,导致痰液排泄障碍,进而影响预后。对于重型/危重型新型冠状病毒肺炎机械通气患者而言,及早采取必要的中西医肺康复干预措施意义重大,不仅有助于缓解呼吸困难症状,而且可缩短住院时间、改善预后。  相似文献   
95.
Abstract

The purpose of this study was to investigate the strength of the relationships between self-efficacy and (i) functional exercise capacity and (ii) physical activity in chronic obstructive pulmonary disease (COPD), and whether self-efficacy assessment type (i.e., COPD symptoms, exercise-task, exercise-barrier, general, falls) and physical activity assessment type (i.e., self-report vs. objective) are moderators. A systematic search of COPD and self-efficacy concepts was conducted using eight databases from inception to 23 January 2019. Studies were included if they provided correlation coefficients of the relationship between self-efficacy and functional exercise capacity or physical activity, were conducted in adults diagnosed with COPD, and were published in English-language journals. A total of 14 correlation coefficients were included in the self-efficacy and functional exercise capacity meta-analysis, and 16 in the self-efficacy and physical activity meta-analysis. Data were screened, reviewed, and extracted independently by two reviewers, with discrepancies resolved by a third reviewer. Stronger self-efficacy was associated with better functional exercise capacity (weighted r?=?0.38, 95%CI [0.25, 0.50]), and greater physical activity (weighted r?=?0.25, 95%CI [0.17, 0.34]). Exercise-task self-efficacy had the strongest relationship to functional exercise capacity (weighted r?=?0.64, 95% CI [0.51, 0.73]). For physical activity, the type of self-efficacy most strongly related was inconclusive. In COPD, self-efficacy has a relationship to functional exercise capacity and physical activity, the strength of which is influenced by the choice of self-efficacy measure. An understanding of these relationships will assist clinicians in selecting the self-efficacy measure most closely related to the outcome of interest.  相似文献   
96.

Background

Lung ultrasound can accelerate the diagnosis of life-threatening diseases in adults with respiratory symptoms.

Objective

Systematically review the accuracy of lung ultrasonography (LUS) for emergency diagnosis of pneumonia, acute heart failure, and exacerbation of chronic obstructive pulmonary disease (COPD)/asthma in adults.

Methods

PubMed, Embase, Scopus, Web of Science, and LILACS (Literatura Latino Americana e do Caribe em Ciências da Saúde; until 2016) were searched for prospective diagnostic accuracy studies. Rutter-Gatsonis hierarchical summary receiver operating characteristic method was used to measure the overall accuracy of LUS and Reitsma bivariate model to measure the accuracy of the different sonographic signs. This review was previously registered in PROSPERO (Centre for Reviews and Dissemination, University of York, York, UK; CRD42016048085).

Results

Twenty-five studies were included: 14 assessing pneumonia, 14 assessing acute heart failure, and four assessing exacerbations of COPD/asthma. The area under the summary receiver operating characteristic curve of LUS was 0.948 for pneumonia, 0.914 for acute heart failure, and 0.906 for exacerbations of COPD/asthma. In patients suspected to have pneumonia, consolidation had sensitivity of 0.82 (95% confidence interval [CI] 0.74–0.88) and specificity of 0.94 (95% CI 0.85–0.98) for this disease. In acutely dyspneic patients, modified diffuse interstitial syndrome had sensitivity of 0.90 (95% CI 0.87–0.93) and specificity of 0.93 (95% CI 0.91–0.95) for acute heart failure, whereas B-profile had sensitivity of 0.93 (95% CI 0.72–0.98) and specificity of 0.92 (95% CI 0.79–0.97) for this disease in patients with respiratory failure. In patients with acute dyspnea or respiratory failure, the A-profile without PLAPS (posterior-lateral alveolar pleural syndrome) had sensitivity of 0.78 (95% CI 0.67–0.86) and specificity of 0.94 (95% CI 0.89–0.97) for exacerbations of COPD/asthma.

Conclusion

Lung ultrasound is an accurate tool for the emergency diagnosis of pneumonia, acute heart failure, and exacerbations of COPD/asthma.  相似文献   
97.
98.
ObjectivesSevere acute kidney injury (AKI) is a known risk factor for infection and mortality. However, whether stage 1 AKI is a risk factor for infection has not been evaluated in adults. We hypothesized that stage 1 AKI following cardiac surgery would independently associate with infection and mortality.MethodsIn this retrospective propensity score–matched study, we evaluated 1620 adult patients who underwent nonemergent cardiac surgery at the University of Colorado Hospital from 2011 to 2017. Patients who developed stage 1 AKI by Kidney Disease Improving Global Outcomes creatinine criteria within 72 hours of surgery were matched to patients who did not develop AKI. The primary outcome was an infection, defined as a new surgical-site infection, positive blood or urine culture, or development of pneumonia. Secondary outcomes included in-hospital mortality, stroke, and intensive care unit (ICU) and hospital length of stay (LOS).ResultsStage 1 AKI occurred in 293 patients (18.3%). Infection occurred in 20.9% of patients with stage 1 AKI compared with 8.1% in the no-AKI group (P < .001). In propensity-score matched analysis, stage 1 AKI independently associated with increased infection (odds ratio [OR]; 2.24, 95% confidence interval [CI], 1.37-3.17), ICU LOS (OR, 2.38; 95% CI, 1.71–3.31), and hospital LOS (OR, 1.30; 95% CI, 1.17-1.45).ConclusionsStage 1 AKI is independently associated with postoperative infection, ICU LOS, and hospital LOS. Treatment strategies focused on prevention, early recognition, and optimal medical management of AKI may decrease significant postoperative morbidity.  相似文献   
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号